Tonix Pharmaceuticals
Pharmaceuticals, 509 Madison Ave, Chatham, New Jersey, 10022, United States, 51-200 Employees
Phone Number: 21********
Who is TONIX PHARMACEUTICALS
Tonix is a biopharmaceutical company, publicly traded on NASDAQ (ticker: TNXP). The Company is focused on commercializing, developing, discovering and licensing therapeutics to treat and ...
Read More
-
Headquarters: 509 Madison Ave, Chatham, New Jersey, 10022, United States
-
Date Founded: 2007
-
Employees: 51-200
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
-
CEO:
Seth Lederman
Email
Phone
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from TONIX PHARMACEUTICALS
Tonix Pharmaceuticals Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Tonix Pharmaceuticals
Answer: Tonix Pharmaceuticals's headquarters are located at 509 Madison Ave, Chatham, New Jersey, 10022, United States
Answer: Tonix Pharmaceuticals's phone number is 21********
Answer: Tonix Pharmaceuticals's official website is https://tonixpharma.com
Answer: Tonix Pharmaceuticals's revenue is $50 Million to $100 Million
Answer: Tonix Pharmaceuticals's SIC: 2834
Answer: Tonix Pharmaceuticals's NAICS: 325412
Answer: Tonix Pharmaceuticals has 51-200 employees
Answer: Tonix Pharmaceuticals is in Pharmaceuticals
Answer: Tonix Pharmaceuticals contact info: Phone number: 21******** Website: https://tonixpharma.com
Answer: Tonix is a biopharmaceutical company, publicly traded on NASDAQ (ticker: TNXP). The Company is focused on commercializing, developing, discovering and licensing therapeutics to treat and prevent human disease. Tonix markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg. Zembrace SymTouch and Tosymra are each indicated for the treatment of acute migraine with or without aura in adults. Tonixs development portfolio is composed of central nervous system (CNS), rare disease, immunology and infectious disease product candidates. Tonixs CNS development portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. The Companys immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer. Tonixs infectious disease pipeline consists of a vaccine in development to prevent smallpox and monkeypox, which also serves as the live virus vaccine platform or recombinant pox vaccine platform for other infectious diseases.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month